Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Umbilical Cord Blood for Neonates with HLHS or TGA
NCT03558269Phase 2Unknown
- Sponsor
- Sheba Medical Center
- Start
- Feb 2019
- Primary completion
- May 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous umbilical cord blood reinfusion in traumatic brain injury (TBI), low cardiac output syndrome (LCOS), sponsored by Sheba Medical Center. Status: unknown.
02
Drugs
autologous umbilical cord blood reinfusion
03
Conditions
traumatic brain injury (TBI)low cardiac output syndrome (LCOS)
Beyond the preview
Go deeper on NCT03558269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03558269.